Quantcast

Rally Foundation for Childhood Cancer Research Awards 2014 Grants

May 28, 2014

National Nonprofit Organization Contributes $1.2 Million to Support Pediatric Cancer Research Projects Nationwide

ATLANTA, May 28, 2014 /PRNewswire-USNewswire/ — Rally Foundation for Childhood Cancer Research (Rally), a national nonprofit organization, today announced that it is awarding more than $1.2 million to 30 hospitals across the country as part of its annual funding allocation for 2014.

“Rally enables cutting-edge research to continue what would otherwise not be possible due to the limited funding currently available,” said Dr. Gregory Freidman, Assistant Professor of Pediatrics Neuro-Oncology Program at the University of Alabama at Birmingham and a grant recipient. “The research made possible through Rally will have a direct, positive impact on the lives of children with cancer through the development of newer, improved therapies and vital breakthroughs in the management and care of pediatric cancer patients.”

Rally and its Medical Advisory Board, consisting of leading childhood cancer researchers from across the nation, award grants through a competitive peer review process assuring that the most promising research is funded.

“This year’s grant awardees yet again have very promising proposals that could lead to significant scientific discoveries with tremendous translational applicability in the treatment of childhood cancer,” said Dr. Dai Chung, chair of the Rally Medical Advisory Board and Professor of Surgery at Vanderbilt Children’s Hospital.

Research for childhood leukemias, childhood brain tumors, childhood solid tumors and survivorship studies are among the types of cancer funded through the 2014 Rally Research Grants. This research is taking place at hospitals across the country including Baylor College of Medicine, Dana-Farber Cancer Institute, Emory University, Johns Hopkins University School of Medicine, Seattle Children’s Hospital and The Regents of the University of California, San Francisco. To see a full list of hospitals, visit RallyFoundation.org.

“Rally is thrilled and humbled to be giving more than $1.2 million to fund cutting-edge childhood cancer research projects across the country,” said Rally Founder and CEO Dean Crowe. “The dedication of our volunteers and partners, including The Truth 365, Bear Necessities and Vs. Cancer, continues to help fill the gap in childhood cancer research funding. We are all working for the day when no parent has to hear, ‘I am sorry, there is nothing else we can do.’”

Since its founding in 2005, Rally has distributed more than $5.25 million to more than 80 childhood cancer research projects nationwide, including basic science, fellowships and clinical trials. In a random survey of 24 Rally-funded researchers, more than 70 percent reported publishing their discoveries and presenting findings at conferences. In addition, close to 20 percent have received federal funding or moved onto clinical trials.* These outstanding results clearly demonstrate the strength of Rally’s peer review process.

*Report findings are a result of randomly surveyed Rally-funded researchers.

About Rally Foundation for Childhood Cancer Research (Rally)
Childhood cancer is the number one disease killer of kids ages 0 to 15. Rally, a 501(c)(3) nonprofit organization based in Atlanta, empowers volunteers across the country to raise awareness and funds for childhood cancer research to find better treatments with fewer long-term side effects and, ultimately, cure. Volunteers participate in the Rally Athlete program, which offers half marathon training teams for select national races and other Rally fundraisers. Rally received the Independent Charities Seal of Excellence, and according to independently audited financials, 92 cents of every dollar raised, supports Rally’s mission. For more information, visit RallyFoundation.org.

Media Contact:
Christen McCommon
(w) 404-847-9176
(c) 478-737-4323
christen@rallyfoundation.org

SOURCE Rally Foundation for Childhood Cancer Research


Source: PR Newswire



comments powered by Disqus